{"id": "179784", "url": "https://fevir.net/resources/EvidenceVariable/179784", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/group-assignment"], "versionId": "3", "lastUpdated": "2023-12-01T22:26:01.820Z"}, "name": "Therapeutic_dose_anticoagulation_with_heparin_vs_Usual_care_pharmacologic_thromboprophylaxis", "title": "GroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis", "author": [{"name": "Brian S. Alper"}], "citeAs": "GroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis [EvidenceVariable]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179784. Revised 2023-11-30. Available at: https://fevir.net/resources/EvidenceVariable/179784. Computable resource at: https://fevir.net/resources/EvidenceVariable/179784.", "status": "active", "contact": [{"telecom": [{"value": "support@computablepublishing.com", "system": "email"}]}], "category": [{"name": "Therapeutic-dose anticoagulation with heparin", "valueReference": {"type": "Group", "display": "ExposureDefinition: Therapeutic-dose anticoagulation with heparin", "reference": "Group/179786"}}, {"name": "Usual-care pharmacologic thromboprophylaxis", "valueReference": {"type": "Group", "display": "ComparatorDefinition: Usual-care pharmacologic thromboprophylaxis", "reference": "Group/179785"}}], "handling": "dichotomous", "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status", "valueCodeableConcept": {"coding": [{"code": "active", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type", "display": "Active"}]}}], "publisher": "Computable Publishing LLC", "definition": {"concept": {"coding": [{"code": "defined-in-handling-and-category", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Defined in handling and category elements"}]}}, "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "value": "179784", "system": "https://fevir.net/FOI", "assigner": {"display": "Computable Publishing LLC"}}], "useContext": [{"code": {"code": "evidence-communication", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Evidence Communication"}, "valueCodeableConcept": {"text": "group-assignment"}}], "description": "Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis in multi-platform RCT of anticoagulation for non-critically ill patients with COVID-19", "resourceType": "EvidenceVariable"}